PeptideDB

G150

CAS: 2369751-30-2 F: C18H16Cl2N4O2 W: 391.25

G150 is a highly selective human cyclic GMP-AMP synthase (h-cGAS) inhibitor with an IC50 of 10.2 nM. G150 represses dsDN
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity G150 is a highly selective human cyclic GMP-AMP synthase (h-cGAS) inhibitor with an IC50 of 10.2 nM. G150 represses dsDNA-triggered interferon expression, and G150 can be used for the research of inflammatory[1].
Target IC50: 10.2 nM (h-cGAS)
Invitro G150 (0.1-100 μM; 1 h) affects IFNB1 and CXCL10 expression in human THP1 cells and primary human macrophages[1].G150 (5-10 μM; 1 h) affects dsDNA sensing in THP1 cells and primary human macrophages[1].G150 (0.1-100 μM; 1 h) affects the NF-κB pathway activation in THP1-Dual cells[1]. RT-PCR[1] Cell Line:
Name G150
CAS 2369751-30-2
Formula C18H16Cl2N4O2
Molar Mass 391.25
Appearance Solid
Transport Room temperature in continental US; may vary elsewhere.
Storage
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
Reference [1]. Lama L, et al. Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expression. Nat Commun. 2019 May 21;10(1):2261.